While most variants identified in Sotos patients are loss-of-function, only one disruptive variant has been identified in CRC patients (NSD1 c.7874G>A; p.W2625*), while the others included nine missense predicted pathogenic (REVEL>0.4). This evidence concerns the gene NSD1 and colorectal carcinoma.